# Beam Therapeutics Inc.: Form 8-K, filed Jun 8, 2023

- Company: [Beam Therapeutics Inc.](/companies/beam.md) (CIK 1745999)
- Form: 8-K
- Filed: 2023-06-08
- Accepted by EDGAR: Jun 8, 2023, 16:31 ET
- Period: 2023-06-06
- Accession: 0000950170-23-027026
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1745999/000095017023027026/beam-20230606.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1745999/000095017023027026/

## Items reported

- Item 5.07: Shareholder vote results

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1745999/000095017023027026/beam-20230606.htm

Filed Jun 8, 2023.
Source: SEC EDGAR, the filing index for accession 0000950170-23-027026. Last ingested by Listed: Nov 14, 2026, 12:58 ET. No prices; not investment advice.
